2024 predictions: Experts weigh in on cancer research
Drug Discovery World
FEBRUARY 5, 2024
Brian Gladsden, CEO, Mosaic Therapeutics “The industry has already made tremendous strides in targeted drug discovery in oncology, particularly as the industry moves further away from simply looking at tumour histology and relying more on cancer gene sequencing. In the past 10 years, immunotherapy trials have increased by 430%.
116 
Let's personalize your content